iotaMotion’s robotic-assisted cochlear implantation technology receives US patent

Join Pharma | Login

	Editorial


	CONSIDER THIS DEMAND
	Wednesday, June 11, 2025
	The Laghu Udyog Bharati (LUB), an association of small and micro enterprises headquartered in New Delhi, has recently urged the Union Health Minister to consider a further extension of the deadline, till 2026 end, for implementing the Revised Schedule M
	Past Editorial...

TODAY'S NEWS


10:00 [IST]	iotaMotion’s robotic-assisted cochlear implantation technology receives US patent
09:00 [IST]	Novartis Fabhalta shows statistically significant and clinically meaningful improvements in haemoglobin in new population of patients with PNH

more news >>

TOP NEWS


08:00 [IST]	Multidisciplinary Committee recommends retail price for GSK's cold medicine
08:00 [IST]	Pharma supply chain turns to blockchain for greater traceability, compliance & reduced counterfeits
08:00 [IST]	New SION notified for sodium citrate to boost pharma exports
08:00 [IST]	MSME exhibitors at Pharmac South Expo to get upto 100% reimbursement
08:00 [IST]	Medical experts note AI-powered agents advance quality patient engagement
08:00 [IST]	NPPA to seek advice from subject experts on fixing separate price for cementless knee implants

more news >>

YESTERDAY'S NEWS


17:40 [IST]	NHNE 2025 concludes with record-breaking participation and industry-shaping innovations
17:30 [IST]	Innominds & Celegence ink pact to drive AI-powered regulatory innovation in life sciences
17:15 [IST]	ICICI Bank to fund Rs. 550 crore into Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam
16:45 [IST]	Fujifilm India initiates breast cancer awareness CSR campaign in Apollo Hospitals
16:30 [IST]	HVS Hospitals expands footprint across Mumbai, addition of two new branches in Borivali & Thane
16:15 [IST]	Wockhardt Hospitals, Mira Road, launches premium wellness lounge services to redefine preventive healthcare

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

Leading 30 pharma players boost net earnings growth of 31 per cent in 2024-25 Export of Drug Formulations and Biologicals During the year 2023-24 and From April 2024 to November 2024 Import of Drug Formulations and Biologicals During the year 2023-24 and From April 2024 to November 2024 Import of Bulk Drug and Intermediates (All Countries) During the year 2023-24 and From April 2024 to November 2024 Export of Bulk Drug and Intermediates (All Countries) During the year 2023-24 and From April 2024 to November 2024

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers